Amarin’s Vascepa Approval Seems Fishy for Patients and AMRN Investors

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

What does the FDA's recent approval of Vascepa mean for Amarin stock? Is the company really a target for buyout offers?

The post Amarin’s Vascepa Approval Seems Fishy for Patients and AMRN Investors appeared first on InvestorPlace.

• 2 Toxic Pot Stocks You Should Avoid
• 7 'A'-Rated Stocks to Buy Before 2020
• 7 of the Decade's Fastest-Growing Dividend Stocks
• 5 Cheap Dividend Stocks With High Yields And Annual Increases